Michael Basso

1.8k total citations · 1 hit paper
23 papers, 1.1k citations indexed

About

Michael Basso is a scholar working on Surgery, Immunology and Cell Biology. According to data from OpenAlex, Michael Basso has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Immunology and 5 papers in Cell Biology. Recurrent topics in Michael Basso's work include Cholesterol and Lipid Metabolism (7 papers), Aldose Reductase and Taurine (5 papers) and Cardiovascular Function and Risk Factors (3 papers). Michael Basso is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), Aldose Reductase and Taurine (5 papers) and Cardiovascular Function and Risk Factors (3 papers). Michael Basso collaborates with scholars based in United States, Canada and United Kingdom. Michael Basso's co-authors include T. C. Hohman, Norman E. Cameron, M. A. Cotter, Lei Zhao, Melissa Yarde, Payman Zamani, Zhaoqing Wang, Zhuyin Li, Julio A. Chirinos and Dietmar Seiffert and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Medicinal Chemistry.

In The Last Decade

Michael Basso

23 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction

2020 258 citations Jordana B. Cohen, Sarah J. Schrauben et al. JACC Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Basso United States	15	390	283	253	236	172	23	1.1k
Shuiqing Yu United States	17	497 1.3×	356 1.3×	578 2.3×	454 1.9×	270 1.6×	21	1.4k
P.D. Winocour Canada	20	493 1.3×	238 0.8×	268 1.1×	119 0.5×	384 2.2×	57	1.4k
Hana Joch Switzerland	10	317 0.8×	301 1.1×	368 1.5×	260 1.1×	104 0.6×	11	1.1k
Danielle A. Guimarães Brazil	23	371 1.0×	138 0.5×	330 1.3×	335 1.4×	125 0.7×	39	1.1k
Hiroki Takahashi Japan	20	596 1.5×	217 0.8×	486 1.9×	188 0.8×	95 0.6×	62	1.4k
Mizuo Mifune Japan	20	334 0.9×	154 0.5×	518 2.0×	152 0.6×	338 2.0×	36	1.2k
Agnès Sassolas France	21	412 1.1×	388 1.4×	312 1.2×	212 0.9×	412 2.4×	43	1.2k
Tamotsu Yokota Japan	21	196 0.5×	184 0.7×	589 2.3×	162 0.7×	315 1.8×	37	1.4k
Jeffrey Brandimarto United States	12	540 1.4×	155 0.5×	556 2.2×	265 1.1×	287 1.7×	16	1.2k
Takeyoshi Murano Japan	24	347 0.9×	334 1.2×	292 1.2×	265 1.1×	418 2.4×	52	1.2k

Countries citing papers authored by Michael Basso

Since Specialization

Citations

This map shows the geographic impact of Michael Basso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Basso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Basso more than expected).

Fields of papers citing papers by Michael Basso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Basso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Basso. The network helps show where Michael Basso may publish in the future.

Co-authorship network of co-authors of Michael Basso

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Basso. A scholar is included among the top collaborators of Michael Basso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Basso. Michael Basso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chirinos, Julio A., Alena Orlenko, Lei Zhao, et al.. (2020). Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction. Journal of the American College of Cardiology. 75(11). 1281–1295. 153 indexed citations

Cohen, Jordana B., Sarah J. Schrauben, Lei Zhao, et al.. (2020). Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction. JACC Heart Failure. 8(3). 172–184. 258 indexed citations breakdown →

Prenner, Stuart B., Anupam Kumar, Lei Zhao, et al.. (2019). Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial). The American Journal of Cardiology. 125(4). 575–582. 30 indexed citations

Wurtz, Nicholas R., Andrew Q. Viet, Scott A. Shaw, et al.. (2018). Potent Triazolopyridine Myeloperoxidase Inhibitors. ACS Medicinal Chemistry Letters. 9(12). 1175–1180. 19 indexed citations

Hu, Baihua, Rayomand J. Unwalla, Igor Goljer, et al.. (2010). Identification of Phenylsulfone-Substituted Quinoxaline (WYE-672) as a Tissue Selective Liver X-receptor (LXR) Agonist. Journal of Medicinal Chemistry. 53(8). 3296–3304. 32 indexed citations

Quinet, Elaine, Michael Basso, Anita Halpern, et al.. (2009). LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse. Journal of Lipid Research. 50(12). 2358–2370. 82 indexed citations

Quinet, Elaine, Anita Halpern, Michael Basso, et al.. (2008). Abstract 3619: A Novel Tissue Selective LXR Ligand, WYE-672. Circulation. 118. 1 indexed citations

DiBlasio-Smith, Elizabeth A., Maya Arai, Elaine Quinet, et al.. (2008). Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. Journal of Translational Medicine. 6(1). 59–59. 34 indexed citations

Nambi, Ponnal, Michael Basso, Liang Chen, et al.. (2007). Abstract 1453: LXR-623, a novel Liver X Receptor modulator, displays neutral lipid effects in Cholesteryl Ester Transfer Protein-expressing species and inhibits atherosclerotic lesion progression in Low Density Lipoprotein receptor knockout mice. Circulation. 116. 3 indexed citations

10.

Leik, Courtney E., et al.. (2007). GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II‐mediated pressor responses in Sprague–Dawley rats. British Journal of Pharmacology. 151(4). 450–456. 31 indexed citations

11.

Nambi, P, Michael Basso, Li Chen, et al.. (2006). Tu-P8:325 Way-254011, a novel liver X receptor modulator, inhibitss atherosclerotic lesion progression in apolipoprotein E knockout mice. Atherosclerosis Supplements. 7(3). 256–256. 1 indexed citations

12.

Basso, Michael, P Nambi, & S J Adelman. (2003). Effect of sirolimus on the cholesterol content of aortic arch in ApoE knockout mice. Transplantation Proceedings. 35(8). 3136–3138. 28 indexed citations

13.

Elloso, M. Merle, et al.. (2003). Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice. American Journal of Transplantation. 3(5). 562–569. 106 indexed citations

14.

Jacot, J. L., et al.. (2000). Retinal Capillary Dilation: Early Diabetic-Like Retinopathy in the Galactose-Fed Rat Model. Journal of Ocular Pharmacology and Therapeutics. 16(2). 167–172. 6 indexed citations

15.

Cameron, Norman E., M. A. Cotter, A. M. Jack, Michael Basso, & T. C. Hohman. (1999). Protein kinase C effects on nerve function, perfusion, Na + ,K + -ATPase activity and glutathione content in diabetic rats. Diabetologia. 42(9). 1120–1130. 106 indexed citations

16.

Cameron, Norman E., M. A. Cotter, Michael Basso, & T. C. Hohman. (1997). Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia. 40(3). 271–281. 128 indexed citations

17.

Dvornik, D., Thomas C. Hohman, & Michael Basso. (1996). Aminoguanidine does not inhibit aldose reductase activity in galactose-fed rats. Journal of Diabetes and its Complications. 10(1). 23–30. 5 indexed citations

18.

Laver, Nora, et al.. (1996). Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509.. PubMed. 37(6). 1149–56. 27 indexed citations

19.

Kamijo, Mikiko, Michael Basso, Paul Cherian, Thomas C. Hohman, & Anders A. F. Sima. (1994). Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy. Diabetes Research and Clinical Practice. 25(2). 117–129. 16 indexed citations

20.

Brunelli, Matteo, et al.. (1978). [Giant lipoma of the sciatic nerve (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 104(3). 221–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact